Elliott Eyes Bet on Pipeline Carrying Russian Gas
Elliott Investment Management is in talks to buy a stake in a package of infrastructure assets, including a pipeline that carries Russian natural gas to Europe—a deal that could form a template for reviving Moscow's once-mighty energy business by involving American investors.
The U.S. hedge fund, headed by billionaire founder Paul Singer, is considering a stake in the Bulgarian extension of the TurkStream pipeline, along with access to a network of data centers, data cables and other infrastructure assets, according to people familiar with the matter.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Alaska Sustainable Energy Conference 2025 left unspoken what Alaskans truly value
The Canning River, seen here in 2018, flows from the Brooks Range into the Beaufort Sea along the western edge of the Arctic National Wildlife Refuge. (Photo by Lisa Hupp/U.S. Fish and Wildlife Service) At the conclusion of the 2025 Alaska Sustainable Energy Conference much attention was given to profitability of fossil fuels, while far less was said about the meaning of 'sustainability' itself. In fact, both Alaskans and the principles of sustainability were notably absent from the conference's central themes and many of its attendees. From the outset, the federal government's priority appeared to be reassuring foreign interests of the United States' continued ability to sell off Alaska piece by piece. Conference organizers, led by Gov. Mike Dunleavy appeared eager as regulatory protections continue to be rolled back by the Trump administration. Federal officials, including U.S. Interior Secretary Doug Burgum, U.S. Energy Secretary Chris Wright, and Environmental Protection Agency Administrator Lee Zeldin, expressed strong support for the further weakening of environmental safeguards to unilaterally advance long-contested development projects across Alaska. Many attendees represented corporate interests excited to profit from new extraction opportunities or potential buyers, watching to see if the administration follows through on promises to mine Alaska's oil, gas, and critical minerals. These companies appeared enthusiastic to exploit the land with minimal oversight and a lack of local consent. The audience was left with a misleading impression of Alaskan support. At the center of ongoing and proposed projects, such as Red Dog mine, Graphite One, and Ambler Road, was the largest item for sale: a natural gas reservoir on the North Slope. The proposed Alaska liquid natural gas pipeline, currently led by the Alaska Gasoline Development Corp. and New York-based Glenfarne Group LLC, would extract natural gas from subsurface carbon and transport it 800 miles south to Nikiski for export. The estimated almost $40 billion project promises only temporary jobs and infrastructure. Environmentally, natural gas poses risks similar to coal and oil. It is composed primarily of methane, a potent greenhouse gas. Inevitable gas leaks during extraction and transportation can release up to 10% of methane before combustion, with the remainder ultimately emitted as carbon dioxide. These outcomes reflect outdated, combustion-based energy models. Regarding Alaska's wildlife and people, cabinet members seemed to dismiss concerns after brief visits, suggesting the animals are happy and that communities would benefit from further resource development despite evidence to the contrary. The 'resource curse' is a paradox that explains the economic dynamics of regions rich in natural resources, but limited in democratic representation. Extraction projects often introduce new workers, housing, and other infrastructure at great cost to local communities. Despite generating profits for corporate sponsors, these projects typically result in a net loss for the public. Workers are imported from out of state, while profits are exported. Local towns are then responsible for maintaining infrastructure without receiving corresponding benefits like revenue to support housing, health care or affordable energy. As finite resources are exhausted, companies maintain profit margins while community returns diminish. Once operations end, communities are often left with environmental damage and abandoned development, economically and socially worse off than before. Alaska's economy remains heavily reliant on oil and gas. As existing operations decrease in yield, public education and health care routinely face budgetary cuts. The natural gas reserve would only provide exports for a few decades, but its development would cause irreparable environmental damage, and leave Alaska facing another energy crisis within a generation. Why Gov. Dunleavy labeled this conference 'sustainable' remains unclear. It is unrealistic to claim the pipeline would benefit any of the roughly 190 communities beyond the Railbelt. While the state invests in LNG exports, rural towns reliant on diesel will face rising costs and health issues, including cancer risks. Regardless of one's stance on oil and gas, Chris Wright, the U.S. Secretary of Energy, himself stated: 'Energy… it's about people and math.' However, his equation solves for profit, while Alaska's equation for energy must begin and end with the voices and needs of the people. Scientists attending the summit this week in an official capacity were restricted to framing oil and gas as the primary development priority. This narrowed the conversation and sidelined discussions around advances in technology such as solar, wind, hydroelectric, and geothermal energy. Still, a handful of sustainability advocates attended as guests, business owners, protesters, and speakers. One speaker, Lesil McGuire, senior advisor with New Energy Alaska, an advocacy coalition that promotes renewable energy noted, 'Solar arrays can be propped up in a number of weeks.' As of 2020 solar energy has become cheaper to install and maintain than fossil fuels. Alaska needs energy infrastructure tailored to its unique environment, focused on long-term self reliance through renewable sources. Current examples include solar installations in the Northwest Arctic Borough, microgrid cooperatives, and heat pump incentives in Southeast Alaska. A cursory glance shows Alaska's capacity for renewable energy that could be faster to build and more cost effective than the LNG pipeline. In reality the conference didn't need to be held in Alaska, as Alaskans themselves played a minimal role. Led by Gov. Dunleavy, the 'Alaska Sustainable Energy Conference 2025' resembled government-backed promotion of the oil and gas industry and signaled extraction projects could move forward without oversight and regardless of local stakeholder's needs or opposition. International representatives seemed to be promised fuel for import, and out-of-state corporations appeared to be invited to profit at the expense of Alaska's environment. Renewable energy has been viable for decades and continues to become more efficient. Given a voice and a seat at the table, many Alaskans and Americans would likely favor local, self-sufficient renewables for lower prices and long-term reliability. Natural gas in Alaska will run out in this lifetime, do nothing to reduce costs in the majority of Alaskan communities, and may cause permanent harm to the environment. The United States and Alaska are not in need of a technological revolution in fossil fuels, but an information revolution in renewable energy. It is vitally important that all Alaskan voices are heard. Alaska values pristine wilderness, supports true sustainability, and is not for sale.
Car and Driver
3 hours ago
- Car and Driver
Report: Most 2026 BMW Models Will Receive a Price Hike on July 1
BMW will raise prices on many of its 2026 models starting on July 1, according to a report from CarsDirect. The increase will amount to about 2 percent of the existing MSRP, with the price hike ranging from $1100 to $2500. Several models will escape the price bump, including the 2026 iX SUV and 2026 M2 coupe. The vast majority of BMW models will likely get more expensive starting next month. As reported by CarsDirect, a bulletin was sent to BMW dealerships last week stating that the MSRP of most 2026 BMW models will go up by 1.9 percent beginning on July 1, 2025. The price increases will reportedly not affect 2025 BMW inventory. BMW has so far released pricing for many, but not all, of its 2026 model year lineup, with pricing for models such as the 7-series, X1, and 2-series not yet available. The nearly 2 percent price increase also won't affect every model in BMW's lineup. The main exceptions are its 2026-model-year EVs, the i5 and the iX. (Pricing for the 2026 i4 and i7 has not been published.) The Alpina XB7, 2026 2-series Gran Coupe, and 2026 M2 are also reportedly unaffected. BMW On the top end, the price hikes amount to $2500 for models such as the X5 M, which rises from $127,200 to $129,700, according to CarsDirect. The lowest increases are for the 4-series Coupe and Z4 roadster, which each see a bump of $1100. These figures exclude the destination fee, which Car and Driver reports as part of the price, and it's unclear if the freight charge will change for any BMW models when the calendar turns to July. CarsDirect says the bulletin doesn't blame the import tariffs implemented by the U.S. government for the price hikes, instead stating that the rises are "in line with past pricing communications, and account for inflation and enhancements to standard equipment where applicable." Slight increases in the MSRP are common for new model years, but we wouldn't be surprised if the tariffs are also playing a factor. A previous report from Automotive News stated that BMW wouldn't raise prices on imported models until the end of June. We've reached out to BMW for comment regarding these reported price increases and will update the story if we hear back. Caleb Miller Associate News Editor Caleb Miller began blogging about cars at 13 years old, and he realized his dream of writing for a car magazine after graduating from Carnegie Mellon University and joining the Car and Driver team. He loves quirky and obscure autos, aiming to one day own something bizarre like a Nissan S-Cargo, and is an avid motorsports fan.
Associated Press
3 hours ago
- Associated Press
Sire Search Identifies Top 5 Platforms to Boost Biotech Career Growth
Hey, biotech folks! Whether you're a lab whiz itching to land your next role in drug discovery or a hiring manager hunting for the perfect candidate to boost your startup, the life sciences world is buzzing with potential. But, real talk—finding the right job or talent in this fast-moving industry can feel like trying to spot a single cell under a microscope. Overwhelming, right? That's were specialized recruitment websites swoop in like career superheroes. I've rounded up the five best platforms to help you navigate the biotech job maze, and guess what? SIRE Searchis leading the charge with its sharp, tailored approach. Let's dive in and see why these sites are your new allies for crushing it in biotech! 1. – Your Career's Guide A recruitment platform that feels like it knows you better than your lab partner. That's SIRE Searchin a nutshell. Based in Haarlem, Netherlands—a charming spot, by the way—SIRE has been shaking up the life sciences scene since 2012. Whether you're into pharmaceuticals, medical devices, or even fast-moving consumer goods (yep, they've got that covered), SIRE's the place to find your next career win. Their reverse recruitment approach is like a secret weapon. Instead of tossing a pile of job listings your way, they do the heavy lifting first. Using data and market insights, their team—packed with recruiters who actually get biotech—handpicks roles that match your skills and goals. One Trustpilot reviewer raved, 'SIRE landed me a job that's spot-on for my expertise. They were quick and genuinely cared!' With a 4-star rating, they're clearly hitting the mark. 2. – The U.S. Biotech Hub Let's zip over to the States for BioSpace, a heavyweight for biotech and pharma jobs. With over 4,000 active listings, this sites like a treasure chest for anyone looking to dive into or climb higher in the U.S. biotech scene. From lab techs to execs, BioSpace has roles for every step of your journey. What's the deal with BioSpace? It's more than a job board—it's a whole community. You can narrow down searches by niche (like gene therapy or clinical trials) or location, so you're not stuck scrolling through irrelevant posts. They also dish out extras like industry updates, career tips, and their 'Best Places to Work' report, which is like a VIP list for biotech companies. The downside? It's mostly U.S.-focused, so it doesn't have SIRE's global reach. But for North American job seekers, BioSpace is a goldmine. 3. – Your Global Career Connector Dreaming of a biotech career that takes you worldwide? Meet Preclinical. With offices in places like the UK, Singapore, and the U.S., this platform hooks up candidates with roles in everything from drug development to regulatory affairs. It's like having a friend who knows the hottest jobs on every continent. Proclinical's strength is precision. Their recruiters dig into what employers need—skills, culture, the whole package—and match that with a huge candidate network. It's like they're playing career matchmaker, and they're good at it. They don't have SIRE's data-driven reverse recruitment trick, but their global scope is a big win for anyone wanting to think beyond borders. Plus, their blog's full of practical tips, like how to tweak your CV or nail an interview, which is super handy. 4. – The Science Lover's Hangout Next up is New Scientist Jobs, the friendly, all-purpose spot for science buffs. It covers a range of fields, but its biotech section is packed with roles in areas like vaccine research or molecular biology. Whether you're in Europe, the U.S., or elsewhere, this platform's global vibe makes it a welcoming place to explore. Why's it worth your time? It's easy to navigate, with filters to zero in on jobs by expertise or location. Their blog's a gem, too, with career advice and industry scoops that keep you in the loop. It's not as biotech-focused as SIRE, so you might need to sift a bit to find the right role. But if you're curious and love poking around, New Scientist Jobs is a solid bet. 5. – The Job-Finding Shortcut Last up is BioPharmGuy, the quirky underdog we're rooting for. Instead of hosting job listings, it points you straight to biotech company career pages, helping you dodge crowded job boards and find hidden opportunities. It's like a map of buried treasure. You can search by region or niche—like cell therapy or diagnostics—which makes it easy to target your sweet spot. The catch? It's more of a DIY experience, so you won't get the hands-on support you'd find with SIRE's recruiters. But for those who enjoy a bit of career sleuthing, BioPharmGuy is a clever tool to stand out. Why SIRE Search Takes the Crown? Let's give a shoutout to SIRE Searchfor stealing the show. Their reverse recruitment strategy is like having a career coach who's always one step ahead. By tapping into data and market trends, they find roles that fit you like a perfectly calibrated pipette. Their recruiters are biotech enthusiasts who speak your language and genuinely care about your next step. SIRE's focus on Europe—where biotech is thriving—gives them the edge, with connections to everyone from tiny startups to massive corporations. One candidate on Trustpilot said, 'SIRE made my job search feel effortless. They found me a role that's exactly where I want to be.' Employers love them, too, thanks to their knack for delivering candidates who nail both the skills and the vibe. Whether you're after a temp role or a corner office, SIRE's your partner in crime. 5 Tips to Nail Your Biotech Job Hunt Ready to hit these websites and land your dream role? Here's how to make it happen: Let's Wrap It Up The biotech world is full of possibilities, and these websites are your key to unlocking them. SIRE Searchleads the pack with its smart, personalized approach and deep love for life sciences. BioSpace, Preclinical, New Scientist Jobs, and BioPharmGuy are also stellar, each bringing their spark to the table. So, spruce up that resume, dive into these platforms, and get ready to make waves in biotech. Your next big opportunity is out there—grab it! Media Contact Company Name: Sire Search Email: Send Email Address:Staten Bolwerk City: 12011 MK Haarlem Country: Netherlands Website: Press Release Distributed by To view the original version on ABNewswire visit: Sire Search Identifies Top 5 Platforms to Boost Biotech Career Growth
